DoctorsAlejandra Gonzalez-Calle, PhD

Alejandra Gonzalez-Calle, PhD

Alejandra Gonzalez-Calle, PhD

Title: Assistant Professor of Research Ophthalmology

Department: Ophthalmology

Biography and Education


Dr. Gonzalez-Calle focuses on applying engineering approaches and discoveries towards addressing retinal disorders with no immediate cures. Her multidisciplinary translational research includes using non-invasive controlled electrical stimulation to induce neuroprotective changes in the retina, which can help slow down the progression of retinal diseases like age-related macular degeneration (AMD), retinitis pigmentosa (RP) and glaucoma (POAG). Additionally, she has worked on the development of a novel reversibly viscous hydrogel to provide a temporary patch to occlude penetrating injuries and prevent further loss of ocular tissue in collaboration with Dr. Whalen. Dr. Gonzalez-Calle is also passionate about clinical research and has experience working closely with patients who have received the retinal prostheses Argus II to study the effect of stimulation parameters on percept color and percept shape with the goal of providing higher resolution prosthetic vision to enable patient independence and improved quality of life.


  • Escuela de Ingeniería de Antioquia, B.S., Biomedical Engineering, 2010
  • University of Southern California, M.S., Biomedical Engineering, 2013
  • University of Southern California, Ph.D., Biomedical Engineering, 2017


  • USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, Postdoctoral Research Associate, March 2018 – May 2021



  • Master’s BMES Researcher Award, University of Southern California Viterbi School of Engineering, August 2012
  • EMBC2016 NSF Award for Young Professionals, USC Office of Postdoctoral Affairs, USC Office of Postdoctoral Affairs, August 2016
  • USC Provost’s Postdoctoral Scholar Research Grant ($25,000), USC Office of Postdoctoral Affairs, October 2018
  • “Mort” Arditti Award for Excellence, USC Ginsburg Institute for Biomedical Therapeutics, December 2020